Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML

Alix Dubois; Nathan Furstoss; Anne Calleja; Marwa Zerhouni; Thomas Cluzeau; Coline Savy; Sandrine Marchetti; Mohamed Amine Hamouda; Sonia Boulakirba; François Orange; Sandra Lacas-Gervais; Jean-Michel Karsenti; Nicolas Mounier; Jérôme Tamburini; Alexandre Puissant; Frederic Luciano; Arnaud Jacquel; Patrick Auberger; Guillaume Robert

doi:10.1038/s41375-020-0969-8

Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML

Leukemia. 2020 Sep;34(9):2544. doi: 10.1038/s41375-020-0969-8.

Authors

Alix Dubois^#^{1

2

3}, Nathan Furstoss^#^{1

2

3}, Anne Calleja^{1

2

4}, Marwa Zerhouni^{1

3}, Thomas Cluzeau^{1

2

4}, Coline Savy^{1

2

3}, Sandrine Marchetti^{1

2

3}, Mohamed Amine Hamouda^{1

2

3}, Sonia Boulakirba^{1

2

3}, François Orange^{1

5}, Sandra Lacas-Gervais^{1

5}, Jean-Michel Karsenti⁴, Nicolas Mounier^{1

4}, Jérôme Tamburini⁶, Alexandre Puissant⁷, Frederic Luciano^{1

2

3}, Arnaud Jacquel^{1

2

3}, Patrick Auberger^#^{1

2

3

4}, Guillaume Robert^#^{8

9

10}

Affiliations

¹ Université Côte d'Azur, Nice, France.
² Inserm U1065, C3M, Team: Myeloid Malignancies and Multiple Myeloma, Nice, France.
³ Equipe Labellisée par la Fondation ARC, Paris, France.
⁴ CHU de Nice, Département d'Hématologie Clinique, Nice, France.
⁵ Centre Commun de Microscopie Appliquée, Nice, France.
⁶ Institut Cochin, CNRS, UMR 8104, INSERM U1016, Université Paris Descartes, Paris, France.
⁷ Inserm U944, Institut Universitaire d'Hématologie, Hôpital St Louis, Paris, France.
⁸ Université Côte d'Azur, Nice, France. robertg@unice.fr.
⁹ Inserm U1065, C3M, Team: Myeloid Malignancies and Multiple Myeloma, Nice, France. robertg@unice.fr.
¹⁰ Equipe Labellisée par la Fondation ARC, Paris, France. robertg@unice.fr.

^# Contributed equally.

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Publication types

Retraction of Publication